Transglutaminase 2: a new player in bronchopulmonary dysplasia?

Witsch Thilo J., Niess Gero, Sakkas Elpidoforos, Likhoshvay Tatyana, Becker Simone, Herold Susanne, Mayer Konstantin, Vadász István, Roberts Jesse D., Seeger Werner, Morty Rory E.

Source: Eur Respir J 2014; 44: 109-121
Journal Issue: July
Disease area: Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Witsch Thilo J., Niess Gero, Sakkas Elpidoforos, Likhoshvay Tatyana, Becker Simone, Herold Susanne, Mayer Konstantin, Vadász István, Roberts Jesse D., Seeger Werner, Morty Rory E.. Transglutaminase 2: a new player in bronchopulmonary dysplasia?. Eur Respir J 2014; 44: 109-121

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchopulmonary dysplasia: a crime of opportunity?
Source: Eur Respir J, 55 (5) 2000551; 10.1183/13993003.00551-2020
Year: 2020



P16 in bronchopulmonary dysplasia: Early determinant of respiratory disease?
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017


Aerosolized IL-1β receptor antgonist: potential prevention of bronchopulmonary dysplasia?
Source: Eur Respir J 2006; 28: Suppl. 50, 361s
Year: 2006

Bullous emphysema in adolescent: is congenital malformation or outcome of bronchopulmonary dysplasia?
Source: International Congress 2019 – Paediatric respiratory diseases
Year: 2019

Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia
Source: Eur Respir J 2007; 30: Suppl. 51, 55s
Year: 2007

Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017

Epithelial pIgR: A new player in idiopathic pulmonary fibrosis?
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018

Prediction of bronchopulmonary dysplasia
Source: Annual Congress 2009 - Neonatal respiratory disorders
Year: 2009

Pathogenesis of bronchopulmonary dysplasia
Source: Eur Respir Monogr 2021; 92: 50-67
Year: 2021


Dysregulated elastin remodelling in bronchopulmonary dysplasia: a role for lysyl oxidases?
Source: Eur Respir J 2007; 30: Suppl. 51, 377s
Year: 2007

Broncho-pulmonary dysplasia: One disease or two
Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)
Year: 2009



Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia.
Source: International Congress 2017 – Infant lung disease: physiology, assessment and novel therapies 
Year: 2017




Treating allergic bronchopulmonary aspergillosis: the way forward
Source: Eur Respir J 2016; 47: 385-387
Year: 2016


Regulation of microRNA-mRNA target pairs in a model of bronchopulmonary dysplasia
Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Year: 2012


Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010


Bronchopulmonary dysplasia
Source: Respipedia Article
Year: 2017

Epithelial repair is decreased in the early phase of bronchopulmonary dysplasia
Source: Eur Respir J 2003; 22: Suppl. 45, 140s
Year: 2003

Long term management of bronchopulmonary dysplasia
Source: ERS Webinar 2020: Long term management of bronchopulmonary dysplasia
Year: 2020